Cargando…
CD47 deficiency in tumor stroma promotes tumor progression by enhancing angiogenesis
CD47 is a transmembrane protein that functions as a receptor for thrombospondin-1 (TSP1) and a ligand for inhibitory receptor signal-regulatory protein-α (SIRPα). Blocking the interaction between CD47 on tumor cells and SIRPα on macrophages has been shown to induce antitumor responses. Here we inves...
Autores principales: | Gao, Lu, Chen, Kexin, Gao, Qi, Wang, Xiaodan, Sun, Jian, Yang, Yong-Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410232/ https://www.ncbi.nlm.nih.gov/pubmed/27283989 http://dx.doi.org/10.18632/oncotarget.9899 |
Ejemplares similares
-
Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice
por: Li, Yang, et al.
Publicado: (2020) -
Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells
por: Gao, Qi, et al.
Publicado: (2016) -
Hhip regulates tumor-stroma-mediated upregulation of tumor angiogenesis
por: Agrawal, Vijayendra, et al.
Publicado: (2017) -
CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
por: Zhao, Hui, et al.
Publicado: (2016) -
Co-implanting orthotopic tissue creates stroma microenvironment enhancing growth and angiogenesis of multiple tumors
por: Borgstrom, Per, et al.
Publicado: (2013)